Introductions

Oliver Eng, MD: Aileron Therapeutics Inc (Individual(s) Involved: Self): Stockholder; Alpine Immune Sciences (Individual(s) Involved: Self): Stockholder; ALX Oncology Holdings Inc (Individual(s) Involved: Self): Stockholder; Arbutus Biopharma Corp (Individual(s) Involved: Self): Stockholder; ARK Funds (Individual(s) Involved: Self): Stockholder; Cerevel Therapeutics Holdings Inc (Individual(s) Involved: Self): Stockholder; Iovance Biotherapeutics (Individual(s) Involved: Self): Stockholder; Mediwound Ltd (Individual(s) Involved: Self): Stockholder; Novavax, Inc. (Individual(s) Involved: Self): Stockholder; Phathom Pharmaceuticals Inc (Individual(s) Involved: Self): Stockholder; Tarsus Pharmaceuticals Inc (Individual(s) Involved: Self): Stockholder; Veru Inc (Individual(s) Involved: Self): Stockholder; Zymeworks Inc (Individual(s) Involved: Self): Stockholder

Jonathan B. Greer, MD: I do not have any relevant financial / non-financial relationships with any proprietary interests.